Esomeprazole Magnesium
Product Images NDC 45865-102

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 45865-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp_102 (Pdp 102)

The image shows a prescription label for Esomeprazole Capsules 20 mg, generic for Nexium, labeled by Medsource Pharmaceuticals. The label includes dosage instructions, warnings about possible headaches, and packaging details such as capsule description (dark blue/white, oblong). The label also notes the product NDC 45865-0102-60 and batch-related information, intended for 60 capsules.*

FDA Label Image

Figure 1 (Esomeprazole Magnesium Delayed Release Capsules Us 1)

Chemical structure of esomeprazole magnesium with water of hydration shown as 2 H2O, depicting the magnesium ion complexed with two esomeprazole molecules.*

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Esomeprazole Magnesium Delayed Release Capsules Us 2)

A line graph showing the percent maintained over a 6-month period for Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses, compared to a placebo. The x-axis represents months with scheduled visits, and the y-axis shows the percent maintained, with 40 mg dosage maintaining the highest percentage throughout the period.*

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Esomeprazole Magnesium Delayed Release Capsules Us 3)

A line chart showing the percent maintenance over a 6-month period for Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses compared to placebo. The X-axis represents months with scheduled visits, and the Y-axis represents percent maintained. The chart includes a legend identifying each dosage group and placebo.*

FDA Label Image

Figure 4 (Esomeprazole Magnesium Delayed Release Capsules Us 4)

A line graph depicting the percentage of patients symptom-free over 28 diary days for three groups: Esomeprazole Magnesium Delayed-release Capsules 40 mg, 20 mg, and placebo. The y-axis shows the percent of patients symptom-free, ranging from 0 to 100%, and the x-axis shows the diary day from 0 to 28. The graph displays increasing symptom-free percentages for the medication groups compared to placebo over time.*

FDA Label Image

Figure 5 (Esomeprazole Magnesium Delayed Release Capsules Us 5)

A line graph showing the percent of patients symptom-free over a 28-day diary period. The graph compares three groups: Esomeprazole Magnesium Delayed-release Capsules 40 mg, 20 mg, and Placebo, with the 40 mg and 20 mg doses showing higher symptom-free percentages than placebo throughout the duration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.